FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of ...
Le Lézard11h
Marietta Plastic Surgery Expands Body Contouring Options with Awake Liposuction
Marietta Plastic Surgery is now offering Awake Liposuction, performed by board-certified plastic surgeon Dr. Atanu Biswas. This innovative technique allows for fat removal without general anesthesia, ...
Le Lézard10h
Memorial Healthcare System Participates in Groundbreaking Clinical Trial for Innovative Pleural Effusion Treatment
The trial concluded March 25, and with FDA approval already secured, the device is expected to reach the general market soon after. With its participation, Memorial Healthcare System continues its ...
Labmate Online14h
Australian man whose donations of rare blood saved the lives of millions of babies, dies at 88
James Harrison gave his blood plasma more than 1,100 times to produce ‘anti-D’ medication for James Harrison, known in ...
Medical Dialogues15h
Novel Therapies in Management of Haemolytic Disease of the Fetus and Newborn, reveals research
Haemolytic disease of the fetus and newborn (HDFN) occurs when there is transplacental passage of maternal immunoglobulin G ...
Physician's Weekly19h
Comparison of Chlorhexidine and Povidone Iodine for PIE Prevention
The following is a summary of “Chlorhexidine Versus Povidone-Iodine for Intravitreal Injection Antisepsis: A Systematic ...